Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1 #
Open Access
- 29 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 50 (5) , 1597-1605
Abstract
Mutations in ATP8B1 cause progressive familial intrahepatic cholestasis type 1 (PFIC1) and benign recurrent intrahepatic cholestasis type 1 (BRIC1), forming a spectrum of cholestatic disease. Whereas PFIC1 is a progressive, endstage liver disease, BRIC1 patients suffer from episodic periods of cholestasis that resolve spontaneously. At present it is not clear how the type and location of the mutations relate to the clinical manifestations of PFIC1 and BRIC1. ATP8B1 localizes to the canalicular membrane of hepatocytes where it mediates the inward translocation of phosphatidylserine. ATP8B1 interacts with CDC50A, which is required for endoplasmic reticulum exit and plasma membrane localization. In this study we analyzed a panel of missense mutations causing PFIC1 (G308V, D554N, G1040R) or BRIC1 (D70N, I661T). In addition, we included two mutations that have been associated with intrahepatic cholestasis of pregnancy (ICP) (D70N, R867C). We examined the effect of these mutations on protein stability and interaction with CDC50A in Chinese hamster ovary cells, and studied the subcellular localization in WIF-B9 cells. Protein stability was reduced for three out of six mutations studied. Two out of three PFIC1 mutant proteins did not interact with CDC50A, whereas BRIC1/ICP mutants displayed reduced interaction. Importantly, none of the PFIC1 mutants were detectable in the canalicular membrane of WIF-B9 cells, whereas all BRIC1/ICP mutants displayed the same cellular staining pattern as wild-type ATP8B1. Our data indicate that PFIC1 mutations lead to the complete absence of canalicular expression, whereas in BRIC1/ICP residual protein is expressed in the canalicular membrane. Conclusion: These data provide an explanation for the difference in severity between the phenotypes of PFIC1 and BRIC1. (Hepatology 2009.)Keywords
This publication has 36 references indexed in Scilit:
- Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol ContentJournal of Biological Chemistry, 2009
- ATP8B1 Deficiency Disrupts the Bile Canalicular Membrane Bilayer Structure in Hepatocytes, But FXR Expression and Activity Are MaintainedGastroenterology, 2009
- The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptorHepatology, 2008
- Intrahepatic cholestasis of pregnancyOrphanet Journal of Rare Diseases, 2007
- Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liverAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Interleukin-6 regulates hepatic transporters during acute-phase responseBiochemical and Biophysical Research Communications, 2004
- Characterization of mutations in ATP8B1 associated with hereditary cholestasisHepatology, 2004
- Electrophysiological Analysis of the Mutated Na,K-ATPase Cation Binding PocketJournal of Biological Chemistry, 2003
- FIC1 Disease: A Spectrum of Intrahepatic Cholestatic DisordersSeminars in Liver Disease, 2001
- Recurrent Familial Intrahepatic Cholestasis in the Faeroe Islands. Phenotypic Heterogeneity But Genetic HomogeneityHepatology, 1999